Does Rallies show 13F holders for BHVN?

Yes. Rallies tracks hedge fund and 13F ownership data for BHVN, including fund names, share counts, latest tracked quarter, and position changes when available.

Is BHVN research on Rallies investment advice?

No. Rallies provides research, data, and educational context for BHVN. It does not provide personalized investment advice.

BHVN (Biohaven Ltd.) Stock Analysis - Hedge Fund Holdings

Biohaven Ltd. (BHVN) is a publicly traded Healthcare sector company. As of May 21, 2026, BHVN trades at $8.94 with a market cap of $1.28B and a P/E ratio of -0.60. BHVN moved +5.66% today. Year to date, BHVN is -10.88%; over the trailing twelve months it is -45.54%. Its 52-week range spans $7.48 to $55.70. Analyst consensus is buy with an average price target of $19.60. Rallies surfaces BHVN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns BHVN stock?

Hedge funds tracked by Rallies that own BHVN include Redmile Group, Panagora Asset, and Bridgewater Associates. The latest tracked quarter is Jun 30, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Biohaven Ltd..

BHVN Key Metrics

Key financial metrics for BHVN
Metric	Value
Price	$8.94
Market Cap	$1.28B
P/E Ratio	-0.60
EPS	$-14.83
Dividend Yield	0.00%
52-Week High	$55.70
52-Week Low	$7.48
Volume	52
Avg Volume	0
Revenue (TTM)	$859.68M
Net Income	$-930.69M
Gross Margin	85.63%

Top Hedge Funds Holding BHVN

Redmile Group holds 729.51K shares of BHVN, changed -15.90% as of Jun 30, 2025.
Panagora Asset holds 44.46K shares of BHVN, changed -70.63% as of Jun 30, 2025.
Bridgewater Associates holds 20.06K shares of BHVN, changed +0.00% as of Sep 30, 2025.

Latest BHVN News

Biohaven Prepares Mid-2026 Pivotal IgAN, Graves' Trials with $351.8M Cash — May 4, 2026
Biohaven Completes Enrollment in Phase 2 Obesity Trial; Data Due 2H 2026 — Mar 19, 2026
Xenon’s 42.7% Seizure Reduction Spurs Biohaven Premarket Rally — Mar 9, 2026
Biohaven Price Target Rises to $23, BTIG Establishes $24 Forecast — Mar 2, 2026

Recent BHVN Insider Trades

Clark George C. bought 17.00K (~$144.77K) on Nov 17, 2025.
Bailey Gregory bought 400.00K (~$3.00M) on Nov 13, 2025.
CHILDS JOHN W bought 3.33M (~$25.00M) on Nov 13, 2025.

BHVN Analyst Consensus

12 analysts cover BHVN: 0 strong buy, 8 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $19.60.

Common questions about BHVN

Who owns BHVN stock?: Hedge funds tracked by Rallies that own BHVN include Redmile Group, Panagora Asset, and Bridgewater Associates. The latest tracked quarter is Jun 30, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Biohaven Ltd..
Does Rallies show 13F holders for BHVN?: Yes. Rallies tracks hedge fund and 13F ownership data for BHVN, including fund names, share counts, latest tracked quarter, and position changes when available.
Is BHVN research on Rallies investment advice?: No. Rallies provides research, data, and educational context for BHVN. It does not provide personalized investment advice.